These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14709967)

  • 41. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.
    Mao ZL; Wheeler JJ; Clohs L; Beatch GN; Keirns J
    J Clin Pharmacol; 2009 Jan; 49(1):17-29. PubMed ID: 18927241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extrapyramidal syndrome and depression induced by flunarizine.
    Lugaresi A; Montagna P; Gallassi R; Lugaresi E
    Eur Neurol; 1988; 28(4):208-11. PubMed ID: 3416889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute dyskinetic syndrome during chloropromazine treatment of a female patient with CYP2D6 poor metabolism phenotype].
    Beszłej JA; Grzesiak M; Milejski P
    Psychiatr Pol; 2007; 41(4):495-501. PubMed ID: 18046980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
    Arneth B; Shams M; Hiemke C; Härtter S
    Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.
    Borges S; Desta Z; Li L; Skaar TC; Ward BA; Nguyen A; Jin Y; Storniolo AM; Nikoloff DM; Wu L; Hillman G; Hayes DF; Stearns V; Flockhart DA
    Clin Pharmacol Ther; 2006 Jul; 80(1):61-74. PubMed ID: 16815318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
    Henkel V; Mergl R; Schäfer M; Rujescu D; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.
    Whyte EM; Romkes M; Mulsant BH; Kirshne MA; Begley AE; Reynolds CF; Pollock BG
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):542-9. PubMed ID: 16642541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine.
    Nykamp DL; Blackmon CL; Schmidt PE; Roberson AG
    Ann Pharmacother; 2005 Mar; 39(3):543-6. PubMed ID: 15687478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Physiology and biochemistry of extrapyramidal diseases].
    Rinsho Shinkeigaku; 1980 Dec; 20(12):1017-33. PubMed ID: 7249478
    [No Abstract]   [Full Text] [Related]  

  • 51. The association between cytochrome P450-2D6 genotype and prescription of antiparkinsonian drugs in hospitalized psychiatric patients using antipsychotics: a retrospective follow-up study.
    Mulder H; Wilmink FW; Belitser SV; Egberts AC
    J Clin Psychopharmacol; 2006 Apr; 26(2):212-5. PubMed ID: 16633157
    [No Abstract]   [Full Text] [Related]  

  • 52. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacology of the tricyclic antidepressants. II.
    Ban TA
    Appl Ther; 1967 Jan; 9(1):66-75 passim. PubMed ID: 6038747
    [No Abstract]   [Full Text] [Related]  

  • 54. Extrapyramidal effects of antiemetics. Identifying and managing patients at risk.
    Beach S
    Adv Nurse Pract; 2003 Jun; 11(6):40-3. PubMed ID: 12807054
    [No Abstract]   [Full Text] [Related]  

  • 55. [Extrapyramidal syndrome caused by Torecan in childhood].
    Kaszás T
    Orv Hetil; 1981 Sep; 122(37):2283-5. PubMed ID: 7312346
    [No Abstract]   [Full Text] [Related]  

  • 56. [Biochemical disorders in extrapyramidal diseases and possibilities of treatment].
    Jovicić A
    Vojnosanit Pregl; 1979; 36(1):50-2. PubMed ID: 462843
    [No Abstract]   [Full Text] [Related]  

  • 57. [Striatal neurotransmitters and basal ganglia disorders].
    Goto S
    No To Shinkei; 1994 Aug; 46(8):739-50. PubMed ID: 7946630
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmacokinetics of antidepressive agents].
    Tillement JP
    Therapie; 1973; 28(2):249-68. PubMed ID: 4766358
    [No Abstract]   [Full Text] [Related]  

  • 59. [Dental caries caused by longterm use of antidepressive agents].
    Meijer van Putten JB
    Ned Tijdschr Tandheelkd; 1996 Jun; 103(6):236. PubMed ID: 11921472
    [No Abstract]   [Full Text] [Related]  

  • 60. Neuroendocrinology and the extrapyramidal system.
    Villeneuve A
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):673. PubMed ID: 6891826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.